This inventor holds 1 USPTO granted patent. Top assignee: Pierre Fabre Medicament. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Thien Ngoc N'Guyen: Innovator in Immunogenic Agents
Introduction
Thien Ngoc N'Guyen is a notable inventor based in Saint-Julien-en-Genevois, France. He has made significant contributions to the field of immunology, particularly through his innovative work on peptide fragments related to respiratory syncytial virus (RSV).
Latest Patents
N'Guyen holds a patent for a peptide fragment of respiratory syncytial virus protein G, which serves as an immunogenic agent. This patent describes a polypeptide that is characterized by its sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or the bovine respiratory syncytial virus. The patent also covers an immunogenic agent or pharmaceutical composition containing this polypeptide, along with methods for preparing and utilizing it.
Career Highlights
Thien Ngoc N'Guyen is associated with Pierre Fabre Medicament, where he has been instrumental in advancing research and development in immunogenic agents. His work has the potential to impact the treatment and prevention of respiratory infections caused by RSV.
Collaborations
N'Guyen has collaborated with notable professionals in his field, including Michel Trudel and Hans Binz. These collaborations have likely contributed to the depth and breadth of his research and innovations.
Conclusion
Thien Ngoc N'Guyen is a distinguished inventor whose work on immunogenic agents has the potential to make significant contributions to medical science. His innovative approach to addressing respiratory syncytial virus through peptide fragments showcases his expertise and dedication to advancing healthcare solutions.